Loading patent…
AssigneesThe United States of America as represented by the Department of Health and Human Services, The Board of Trustees of the University of Illinois
InventorsVadim N. Gladyshev, Dolph L. Hatfield, Kuan-Teh Jeang, Alan Diamond, John C. Wootton
Estimating the term…
A 15 kDa selenium-containing protein (“selenoprotein”) is disclosed. The protein is shown to be differentially expressed in cancer cells, such as prostate cancer cells. There is a correlation between the presence of a polymorphism at nucleotide positions 811 and 1125 of the 15 kDa selenoprotein gene, and the presence of cancer. This polymorphism is more prevalent in the African American population. The determination of an individual's genotype may be used as an indicator of the need for dietary selenium supplementation to inhibit tumor development. Compositions including the isolated protein, specific binding agents that recognize the protein, as well as underlying nucleic acid sequences are presented, as are methods of using such compositions.
An isolated nucleic acid molecule that encodes a polypeptide comprising the amino acid sequence shown in SEQ ID NO:
An isolated nucleic acid primer molecule, wherein the nucleotide sequence of the molecule consists of 30, 35, 40, 50 or 100 consecutive nucleotides of the complement of SEQ ID NO:
An isolated nucleic acid primer molecule, wherein the nucleotide sequence of the molecule consists of 30, 35, 40, 50, 75 or 100 consecutive nucleotides of SEQ ID NO:
An isolated nucleic acid primer molecule consisting of SEQ ID NO:
Dependencies are inferred from the claim text.